Condition
Relapsed Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Relapsed Leukemia clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Relapsed Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Chemotherapy plus HLA-mismatched G-CSF mobilized peripheral blood cells as a bridge to allogeneic stem cell transplant for relapsed or refractory leukemia | Phase 1 | Beijing | Recruiting | Dec 22, 2025 |
| Roginolisib with venetoclax and rituximab for relapsed or refractory CLL | Phase 1/2 | Boston, Massachusetts | Recruiting | Oct 16, 2024 |
| Olverembatinib plus APG-2575 for children with relapsed or refractory Philadelphia-positive ALL | Phase 1 | Hefei, Anhui and 3 other locations | Recruiting | Aug 10, 2022 |
All recruiting trials (3)
-
Chemotherapy plus HLA-mismatched G-CSF mobilized peripheral blood cells as a bridge to allogeneic stem cell transplant for relapsed or refractory leukemia
This trial will test whether adding an HLA-mismatched G-CSF mobilized peripheral blood mononuclear cell infusion to chemotherapy can safely help people with relapsed or refractory leukemia reach an allogeneic stem cell transplant.
-
Roginolisib with venetoclax and rituximab for relapsed or refractory CLL
This trial will test whether adding roginolisib to the standard venetoclax plus rituximab treatment helps people with relapsed or refractory CLL get deeper and longer remissions.
-
Olverembatinib plus APG-2575 for children with relapsed or refractory Philadelphia-positive ALL
This study tests whether a combination of olverembatinib and APG-2575, with dexamethasone, is safe and potentially effective in children with relapsed or refractory Ph+ ALL who have already tried other TKIs.
Related topics
Quick answers
How many Relapsed Leukemia clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.